Product Information

SIMVASTATIN 40 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0516 per EA under NDC 68180046406. Its NADAC has been published 528 times since Oct 12, 2016.

FDA first approved this application on May 11, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SIMVASTATIN 40 MG TABLET

SIMVASTATIN
$0.0516per EA

Strength

40 mg/1

NDC

68180046406

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

SIMVASTATIN

Approval Type

Generic (ANDA)

FDA Application

ANDA078103

FDA Approved

5/11/2007

TE Code

AB

On Market Since

2/19/2016

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for SIMVASTATIN 40 MG TABLET has been published 528 times since Oct 12, 2016, and over the history we have for it it has risen 48.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0516 per EA
All-time high$0.0701 (Nov 15, 2023)
All-time low$0.0329 (Apr 18, 2018)
52-week high$0.0547
52-week low$0.0516
Median price$0.0428
Average price$0.0458
Largest weekly change+29.8% (Aug 21, 2024)
Weeks tracked528
Tracking sinceOct 12, 2016

Price History

1W

-1.3%

1M

-4.1%

3M

-5.0%

6M

-4.3%

1Y

-0.7%

3Y

-26.5%

5Y

+15.2%

All

+48.1%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SIMVASTATIN 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SIMVASTATIN 40 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.0516 per EA (NDC 68180046406), effective Nov 18, 2026.

How has the price of SIMVASTATIN 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for SIMVASTATIN 40 MG TABLET has risen 48.1%. It has been tracked across 528 weekly CMS publications since Oct 12, 2016.

What are the highest and lowest recorded NADAC prices for SIMVASTATIN 40 MG TABLET?

Since Oct 12, 2016, the NADAC for SIMVASTATIN 40 MG TABLET has ranged from a low of $0.0329 (Apr 18, 2018) to a high of $0.0701 (Nov 15, 2023), with a median of $0.0428 per EA.

Are there cheaper alternatives to SIMVASTATIN 40 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SIMVASTATIN 40 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures SIMVASTATIN 40 MG TABLET?

SIMVASTATIN 40 MG TABLET (NDC 68180046406) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.